Opportunities For Drugmakers To Increase

BMI View: While Indonesia's pharmaceutical market is small compared with its Asia Pacific neighbours, BMI believes factors such as the annual growth the market, combined with rising population numbers and a relatively solid political and economic base, will continue to provide substantial income to companies operating in the country, encouraging multinationals to invest in the Asian

To read the full article, please choose one of the following options: